Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Early Low Rectal Cancer × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Melanoma 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Locally Advanced Rectal Cancer 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Solid Tumor, Adult 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1

Interventions

toripalimab 2 Oxaliplatin 2 Capecitabine 2 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05555888 2025-01-15

TORCH-E

Fudan University

Phase 2 Recruiting

Gastrointestinal

Early Low Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡